Special Report on the Use and Deposit of Funds Raised by Remegen Biopharmaceutical (Yantai) Co., Ltd. in the First Half of 2024.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.